PanGen Biotech Inc (222110) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.33x

PanGen Biotech Inc (222110) has a Cash Flow Reinvestment Rate of 0.33x as of June 2025, reinvesting ₩1.07 Billion (capex ₩56.30 Million plus investments ₩1.01 Billion) from operating cash flow of ₩3.22 Billion. Explore 222110 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.33x

(Capex + Investments) / Operating CF

Total Reinvested

₩1.07 Billion

Capex + Investments

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

PanGen Biotech Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for PanGen Biotech Inc across 1 annual periods. Also explore how large is PanGen Biotech Inc's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for PanGen Biotech Inc (2024–2024)

Year-by-year capital reinvestment analysis for PanGen Biotech Inc. For live market cap and broader valuation context, see market value of PanGen Biotech Inc.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2024	3.59x	₩10.71 Billion	₩2.99 Billion	₩374.12 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow